Cost-effectiveness of biologics in early rheumatoid arthritis.
Finckh
Axel
A
Bansback
Nick
N
Liang
Matthew H
MH
D018501:Antirheumatic Agents / Q000191:economics* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D006801:Humans; D007155:Immunologic Factors / Q000191:economics* / Q000627:therapeutic use
D018501:Antirheumatic Agents; D007155:Immunologic Factors